• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

-844 G/A纤溶酶原激活物抑制剂-1基因多态性与类风湿关节炎中的mRNA表达相关。

The -844 G/A PAI-1 polymorphism is associated with mRNA expression in rheumatoid arthritis.

作者信息

Torres-Carrillo Nora Magdalena, Torres-Carrillo Norma, Vázquez-Del Mercado Mónica, Delgado-Rizo Vidal, Oregón-Romero Edith, Parra-Rojas Isela, Muñoz-Valle José Francisco

机构信息

Instituto de Investigación en Reumatología y del Sistema Músculo Esquelético, Departamento de Biología Molecular y Genómica, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Col. Independencia, Guadalajara, Jalisco 44340, Mexico.

出版信息

Rheumatol Int. 2008 Feb;28(4):355-60. doi: 10.1007/s00296-007-0453-z. Epub 2007 Sep 26.

DOI:10.1007/s00296-007-0453-z
PMID:17899094
Abstract

We assessed whether the -844 G/A polymorphism and mRNA expression of plasminogen activator inhibitor 1 (PAI-1) gene are associated with rheumatoid arthritis (RA). Demographic data, hematological, biochemical parameters, disease activity-disability indexes, -844 G/A genotypes and mRNA expression levels of the PAI-1 gene were determined in 50 RA patients and 50 healthy subjects (HS). Non-significant differences in genotype and allele frequencies related to -844 G/A polymorphism in RA versus HS, were found. High mRNA expression of the PAI-1 gene, was demonstrated in RA versus HS (P < 0.05). In addition, A/A genotype carriers showed increase of PAI-1 mRNA expression (3.1-fold) respect to G/G and G/A genotypes in RA patients (P < 0.05). Our finding suggest an association of A/A -844 PAI-1 genotype with high PAI-1 mRNA expression in RA patients.

摘要

我们评估了纤溶酶原激活物抑制剂1(PAI-1)基因的-844 G/A多态性和mRNA表达是否与类风湿性关节炎(RA)相关。测定了50例RA患者和50例健康对照者(HS)的人口统计学数据、血液学和生化参数、疾病活动-残疾指数、-844 G/A基因型以及PAI-1基因的mRNA表达水平。结果发现,RA患者与HS在-844 G/A多态性的基因型和等位基因频率上无显著差异。与HS相比,RA患者中PAI-1基因的mRNA高表达(P < 0.05)。此外,在RA患者中,A/A基因型携带者的PAI-1 mRNA表达相对于G/G和G/A基因型增加了3.1倍(P < 0.05)。我们的研究结果表明,RA患者中A/A -844 PAI-1基因型与PAI-1 mRNA高表达相关。

相似文献

1
The -844 G/A PAI-1 polymorphism is associated with mRNA expression in rheumatoid arthritis.-844 G/A纤溶酶原激活物抑制剂-1基因多态性与类风湿关节炎中的mRNA表达相关。
Rheumatol Int. 2008 Feb;28(4):355-60. doi: 10.1007/s00296-007-0453-z. Epub 2007 Sep 26.
2
PAI-1 mRNA expression and plasma level in rheumatoid arthritis: relationship with 4G/5G PAI-1 polymorphism.PAI-1 mRNA 表达和类风湿关节炎中的血浆水平:与 4G/5G PAI-1 多态性的关系。
Rheumatol Int. 2012 Dec;32(12):3951-6. doi: 10.1007/s00296-011-2279-y. Epub 2011 Dec 27.
3
Tumor necrosis factor alpha-308 and -238 polymorphisms in rheumatoid arthritis. Association with messenger RNA expression and sTNF-alpha.类风湿关节炎中肿瘤坏死因子α - 308和 - 238多态性。与信使核糖核酸表达及可溶性肿瘤坏死因子α的关联
J Investig Med. 2008 Oct;56(7):937-43. doi: 10.2310/JIM.0b013e318189152b.
4
Plasminogen activator inhibitor-1 C/G polymorphism in relation to plasma levels in rheumatoid arthritis.类风湿关节炎中纤溶酶原激活物抑制剂-1 C/G多态性与血浆水平的关系
Clin Exp Med. 2009 Sep;9(3):223-8. doi: 10.1007/s10238-009-0038-0. Epub 2009 Feb 24.
5
The extrapituitary prolactin promoter polymorphism is associated with rheumatoid arthritis and anti-CCP antibodies in Mexican population.脑垂体外催乳素启动子多态性与墨西哥人群的类风湿关节炎和抗 CCP 抗体有关。
Gene. 2013 Aug 1;525(1):130-5. doi: 10.1016/j.gene.2013.04.068. Epub 2013 May 7.
6
The prevalence of 4G/5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in central serous chorioretinopathy and its association with plasma PAI-1 levels.纤溶酶原激活物抑制剂-1(PAI-1)基因4G/5G多态性在中心性浆液性脉络膜视网膜病变中的患病率及其与血浆PAI-1水平的关系。
Cutan Ocul Toxicol. 2014 Dec;33(4):270-4. doi: 10.3109/15569527.2013.854372. Epub 2014 Jan 22.
7
Plasminogen activator inhibitor-1 (PAI-1) 4 G/5 G polymorphism and endometrial cancer. Influence of PAI-1 polymorphism on tissue PAI-1 antigen and mRNA expression and tumor severity.纤溶酶原激活物抑制剂-1(PAI-1)4G/5G 多态性与子宫内膜癌。PAI-1 多态性对组织 PAI-1 抗原和 mRNA 表达及肿瘤严重程度的影响。
Thromb Res. 2012 Aug;130(2):242-7. doi: 10.1016/j.thromres.2011.10.007. Epub 2011 Nov 4.
8
High expression of interleukine-1 receptor antagonist in rheumatoid arthritis: Association with IL1RN*2/2 genotype.白介素-1 受体拮抗剂在类风湿关节炎中的高表达:与 IL1RN*2/2 基因型相关。
Autoimmunity. 2017 Dec;50(8):468-475. doi: 10.1080/08916934.2017.1412431. Epub 2017 Dec 11.
9
Distribution of --844 G/A and Hind III C/G PAI-1 polymorphisms and plasma PAI-1 levels in Mexican subjects: comparison of frequencies between populations.墨西哥人群中-844 G/A和Hind III C/G纤溶酶原激活物抑制剂-1(PAI-1)基因多态性的分布及血浆PAI-1水平:不同人群间频率比较
Clin Appl Thromb Hemost. 2008 Apr;14(2):220-6. doi: 10.1177/1076029607304747. Epub 2008 Feb 8.
10
PRL -1149T allele (rs1341239) is associated with decreased risk of rheumatoid arthritis in population from southern Mexico: analysis of mRNA expression and PRL serum levels.PRL-1149T 等位基因(rs1341239)与墨西哥南部人群类风湿关节炎风险降低相关:mRNA 表达和 PRL 血清水平分析。
Clin Rheumatol. 2019 Aug;38(8):2089-2097. doi: 10.1007/s10067-019-04517-1. Epub 2019 Mar 25.

引用本文的文献

1
Immunological and Metabolic Causes of Infertility in Polycystic Ovary Syndrome.多囊卵巢综合征不孕症的免疫和代谢原因
Biomedicines. 2023 May 28;11(6):1567. doi: 10.3390/biomedicines11061567.
2
Association between Polymorphisms and Ischemic Stroke in a South Korean Case-Control Cohort.韩国病例对照队列研究中多态性与缺血性脑卒中的关联。
Int J Mol Sci. 2023 Apr 28;24(9):8041. doi: 10.3390/ijms24098041.
3
Plasminogen activator inhibitor-1 promoter sequence variations in idiopathic osteonecrosis of head of femur.特发性股骨头坏死中纤溶酶原激活物抑制剂-1 启动子序列变异。

本文引用的文献

1
Immunologic mechanisms in the pathogenesis of rheumatoid arthritis.类风湿关节炎发病机制中的免疫机制
J Clin Rheumatol. 2005 Jun;11(3 Suppl):S39-44. doi: 10.1097/01.rhu.0000166673.34461.33.
2
Pivotal role of plasminogen-activator inhibitor 1 in vascular disease.纤溶酶原激活物抑制剂1在血管疾病中的关键作用。
Int J Clin Pract. 2005 Jan;59(1):102-6. doi: 10.1111/j.1742-1241.2005.00379.x.
3
Plasminogen activator inhibitor-1.纤溶酶原激活物抑制剂-1
Indian J Med Res. 2021 Jun;154(6):849-856. doi: 10.4103/ijmr.IJMR_496_19.
4
Genotype Variations and Association between PAI-1 Promoter Region (4G/5G and -844G/A) and Susceptibility to Acute Myocardial Infarction and Chronic Stable Angina.纤溶酶原激活物抑制剂-1(PAI-1)启动子区域(4G/5G和-844G/A)的基因型变异及其与急性心肌梗死和慢性稳定性心绞痛易感性的关联。
Cardiol Res Pract. 2021 Jun 25;2021:5551031. doi: 10.1155/2021/5551031. eCollection 2021.
5
SERPINE1 -844 and -675 polymorphisms and chronic obstructive pulmonary disease in a Chinese Han population.中国汉族人群中SERPINE1基因-844和-675多态性与慢性阻塞性肺疾病的关系
J Int Med Res. 2016 Dec;44(6):1292-1301. doi: 10.1177/0300060516664270. Epub 2016 Nov 18.
6
The -844 G>A PAI-1 polymorphism is associated with acute coronary syndrome in Mexican population.-844 G>A纤溶酶原激活物抑制剂-1基因多态性与墨西哥人群的急性冠状动脉综合征相关。
Dis Markers. 2015;2015:460974. doi: 10.1155/2015/460974. Epub 2015 Feb 19.
7
Relationship of metabolic syndrome and its components with -844 G/A and HindIII C/G PAI-1 gene polymorphisms in Mexican children.代谢综合征及其组分与墨西哥儿童中 -844 G/A 和 HindIII C/G PAI-1 基因多态性的关系。
BMC Pediatr. 2012 Mar 29;12:41. doi: 10.1186/1471-2431-12-41.
8
Significant associations of PAI-1 genetic polymorphisms with osteonecrosis of the femoral head.PAI-1 基因多态性与股骨头坏死的显著相关性。
BMC Musculoskelet Disord. 2011 Jul 14;12:160. doi: 10.1186/1471-2474-12-160.
9
Lack of association between plasminogen activator inhibitor type-1 (PAI-1) gene 4G/5G polymorphism and osteoarthritis.纤溶酶原激活物抑制物-1(PAI-1)基因 4G/5G 多态性与骨关节炎之间缺乏关联。
Rheumatol Int. 2012 Jan;32(1):259-62. doi: 10.1007/s00296-010-1737-2. Epub 2011 Jan 15.
10
The plasminogen activator inhibitor-1 (PAI-1) gene -844 A/G and -675 4G/5G promoter polymorphism significantly influences plasma PAI-1 levels in women with polycystic ovary syndrome.纤溶酶原激活物抑制剂-1(PAI-1)基因-844 A/G 和-675 4G/5G 启动子多态性显著影响多囊卵巢综合征女性的血浆 PAI-1 水平。
Endocrine. 2009 Dec;36(3):503-9. doi: 10.1007/s12020-009-9255-2. Epub 2009 Oct 24.
Curr Med Chem. 2004 Sep;11(17):2323-34. doi: 10.2174/0929867043364595.
4
Genotype and allele frequency of PAI-1 promoter polymorphism in healthy subjects from the west of Mexico. Association with biochemical and hematological parameters.
Ann Genet. 2004 Apr-Jun;47(2):155-62. doi: 10.1016/j.anngen.2003.12.001.
5
Association between plasminogen activator inhibitor 1 gene polymorphisms and preeclampsia.纤溶酶原激活物抑制剂1基因多态性与子痫前期之间的关联。
Gynecol Obstet Invest. 2003;56(1):17-22. doi: 10.1159/000072326. Epub 2003 Jul 14.
6
PAI-1 polymorphisms modulate phenotypes associated with the metabolic syndrome in obese and diabetic Caucasian population.纤溶酶原激活物抑制剂-1(PAI-1)基因多态性调节肥胖和糖尿病白种人群中与代谢综合征相关的表型。
Diabetologia. 2003 Sep;46(9):1284-90. doi: 10.1007/s00125-003-1170-0. Epub 2003 Jul 11.
7
Evolving concepts of rheumatoid arthritis.类风湿关节炎的概念演变
Nature. 2003 May 15;423(6937):356-61. doi: 10.1038/nature01661.
8
T(H)1/T(H)2 cytokine profile, metalloprotease-9 activity and hormonal status in pregnant rheumatoid arthritis and systemic lupus erythematosus patients.妊娠类风湿关节炎和系统性红斑狼疮患者的Th1/Th2细胞因子谱、金属蛋白酶-9活性及激素状态
Clin Exp Immunol. 2003 Feb;131(2):377-84. doi: 10.1046/j.1365-2249.2003.02059.x.
9
The impact of the PAI-1 A((-844))G promoter polymorphism on the risk and extent of coronary heart disease.
Thromb Haemost. 2002 Oct;88(4):697-8.
10
Apoptosis as a therapeutic tool in rheumatoid arthritis.细胞凋亡作为类风湿性关节炎的一种治疗手段。
Nat Rev Immunol. 2002 Jul;2(7):527-35. doi: 10.1038/nri846.